Showing results (61-70 of 756) with videos related to
Sort By:
Pageof 76
Transplantation|October 8, 2005
Cyclosporine formulation and Kaposi's sarcoma after renal transplantationDario Cattaneo, Eliana Gotti, Norberto Perico, et al.Scientific Reports|March 22, 2018
Early and late scanning electron microscopy findings in diabetic kidney diseaseSara Conti, Norberto Perico, Rubina Novelli, et al.Journal of Clinical Pharmacology|June 4, 2009
Limited sampling strategies for the estimation of sirolimus daily exposure in kidney transplant recipients on a calcineurin inhibitor-free regimenDario Cattaneo, Monica Cortinovis, Sara Baldelli, et al.Clinical Journal of the American Society of Nephrology : CJASN|October 12, 2007
Pharmacokinetics of mycophenolate sodium and comparison with the mofetil formulation in stable kidney transplant recipientsDario Cattaneo, Monica Cortinovis, Sara Baldelli, et al.Kidney International|July 24, 2009
V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reductionNorberto Perico, Carla Zoja, Daniela Corna, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 25, 2005
High-performance liquid chromatography with ultraviolet detection for therapeutic drug monitoring of everolimusSara Baldelli, Stefano Murgia, Simona Merlini, et al.Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Basiliximab combined with low-dose rabbit anti-human thymocyte globulin: a possible further step toward effective and minimally toxic T cell-targeted therapy in kidney transplantationPiero Ruggenenti, Igor Codreanu, Paolo Cravedi, et al.The American Journal of Pathology|October 8, 2013
Nature and mediators of parietal epithelial cell activation in glomerulonephritides of human and ratPaola Rizzo, Norberto Perico, Elena Gagliardini, et al.Clinical Journal of the American Society of Nephrology : CJASN|February 8, 2023
Effects of Octreotide-Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: Pilot, Randomized, Placebo-Controlled, Cross-Over TrialMatias Trillini, Anna Caroli, Norberto Perico, et al.Nephron|December 13, 2016
Conversion from Brand-Name Neoral to the Generic Ciqorin in Stable Renal Transplant RecipientsMonica Cortinovis, Eliana Gotti, Matias Trillini, et al.Pageof 76